Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DEJR | ISIN: FR0014007ND6 | Ticker-Symbol: X1B
Frankfurt
24.01.25
08:07 Uhr
0,965 Euro
-0,013
-1,33 %
1-Jahres-Chart
HAFFNER ENERGY SA Chart 1 Jahr
5-Tage-Chart
HAFFNER ENERGY SA 5-Tage-Chart
GlobeNewswire (Europe)
213 Leser
Artikel bewerten:
(1)

Haffner Energy and IðunnH2 sign a key agreement to reduce costs and secure carbon supply for Iceland's largest e-SAF project

Finanznachrichten News

Haffner Energy and IðunnH2 sign a key agreement to reduce costs and secure carbon supply for Iceland's largest e-SAF project

Vitry-le-François, France / Reykjavik, Iceland - September 2, 2024 (6.00 pm CEST / 4.00 pm GMT)

Haffner Energy, a leading biomass-to-clean fuels solutions provider, and IðunnH2, a green hydrogen developer, have signed an agreement aimed at integrating Haffner Energy's unique technology in the 65,000 tonnes/year e-SAF facility under development by IðunnH2. The project is located near Keflavík International Airport in Iceland. It is slated to combine green hydrogen from Iceland's renewable power grid with competitive biogenic carbon from Haffner Energy's patented biocarbon gasification technology to produce Sustainable Aviation Fuel (SAF) for use on today's aircraft.

E-SAF, which is projected to account for half of total SAF production by 2050 in Europe, is made from combining green hydrogen with recycled carbon, ideally from a biogenic source. Biogenic carbon typically comes in the form of biogenic CO2, a costly gas to capture, transport, and store. This cost issue is typically compounded by the challenge facing many large-scale hydrogen and e-fuel projects: they are often located in areas with good access to renewable power, but limited access to biogenic carbon, as is the case in Iceland.

Haffner Energy's groundbreaking innovation consists in supplying solid biocarbon (also known as biochar, a byproduct of its biomass thermolysis technology) and gasifying it onsite generating a fundamental change in the economics of e-SAF production.

"Accessing biogenic CO2 from a reliable partner like Haffner Energy is essential to the development of e-SAF and other e-fuels needed to complete Iceland's energy transition. The agreement with Haffner Energy will help us direct Iceland's renewable power onto Iceland's aircraft fleet, to not only to decrease emissions, but also to reduce Iceland's import dependence, improve air quality around Keflavík Airport and bolster energy security," IðunnH2 co-founder and CEO Auður Nanna Baldvinsdóttir says.

"We are thrilled about this exciting project with IðunnH2. Biocarbon is far easier and cheaper to transport and store than CO2, which will make many e-SAF projects economically viable," Philippe Haffner, Haffner Energy co-founder and CEO, points out.

"We are excited to embark on this e-SAF project with IðunnH2 in Iceland, an ideal location for competitive hydrogen production. This agreement bridges the technological and geographical gap, paving the way for competitive e-SAF production with innovative technology," Marcella Franchi, Head of SAF at Haffner Energy, adds.

IðunnH2's 300MW e-SAF facility in Helguvík, Iceland, will produce 65,000 tons of carbon-neutral SAF, thanks to green hydrogen from wind, geothermal and hydropower. SAF will be blended onsite with traditional jet fuel and used on existing fleets and infrastructure. Production is scheduled to start in 2028.

The project aligns with the SAF EU mandate. Supplying the equivalent of 15% of Iceland's projected 2028 total jet fuel demand, this e-SAF facility will allow airlines at Keflavík Airport to exceed the 2030 blending requirement. Icelandair has already committed to using up to 45,000 tonnes each year.

About Haffner Energy

The company, co-founded in France by Marc and Philippe Haffner, supplies cleantech technology for competitive clean fuels production. With 30 years of experience, its operational innovative and patented biomass thermolysis and gasification technology makes it possible to produce Sustainable Aviation Fuel (SAF), as well as renewable gas, hydrogen, and methanol. The company also contributes to the regeneration of the planet through the co-production of biogenic CO2, biochar and biocarbon. Further information is available at www.haffner-energy.com

About IðunnH2

Hydrogen development company IðunnH2 was established in the fall of 2020 by Nanna Baldvinsdóttir and Gylfi Már Geirsson, two seasoned and well-connected experts on the unique Icelandic energy landscape. IðunnH2 leverages the exceptional production conditions in Iceland to create commercially viable hydrogen and e-fuel projects at scale, for the benefit of Icelanders and our shared climate. Further information is available at www.idunnh2.com

Media contacts

Haffner Energy

Laetitia Mailhes
laetitia.mailhes@haffner-energy.com
+33 (0)6 07 12 96 76

IðunnH2

Nanna Baldvinsdóttir
nanna@idunnh2.com
+354 694 1604


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.